NETscape or NEThance: tailoring anti-cancer therapy

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Neutrophils are key innate immunity regulators.
• Neutrophils are increasingly recognized as crucial components within the tumor microenvironment.
• Neutrophil extracellular traps (NETs) are DNA structures released by neutrophils, implicated in cancer progression.

Purpose of the Study:

• To discuss the pivotal roles of NETs in anticancer therapies.
• To examine the dual nature of NETs in influencing treatment outcomes.
• To explore the potential of targeting NETs for improved cancer treatment strategies.

Main Methods:

• Literature review and synthesis of current research on NETs in cancer.
• Analysis of NETs' impact on chemotherapy, radiotherapy, immunotherapy, and targeted therapy.
• Discussion of recent insights into NETs' functions in the tumor microenvironment.

Main Results:

• NETs exhibit a dual role in anticancer treatments, capable of both counteracting and enhancing therapeutic efficacy.
• NETs influence responses across various cancer treatment modalities.
• Evidence suggests NETs can contribute to treatment resistance or synergize with therapies.

Conclusions:

• NETs significantly impact the effectiveness of diverse anticancer treatments.
• Strategic targeting of NETs presents a promising approach for combination therapies.
• Modulating NETs may offer novel strategies to overcome treatment resistance and enhance anticancer efficacy.